Schizophrenia.com
Intra-Cellular Therapies Announces Publication of Lumateperone Pivotal Phase 3 Study in Bipolar Depression
DX'd - Other
everhopeful
September 27, 2021, 12:16pm
1
2 Likes
system
Closed
December 26, 2021, 12:16pm
2
This topic was automatically closed 90 days after the last reply. New replies are no longer allowed.
Related topics
Topic
Replies
Views
Activity
Intra-Cellular Therapies Highlights Lumateperone Presentations
News
3
277
December 13, 2019
Intracellular Theraputics reports mixed results with Lumateperone in Bipolar
News
0
272
July 8, 2019
Intra-Cellular Therapies Announces FDA Acceptance of CAPLYTA® (lumateperone) sNDAs for the Treatment of Bipolar Depression
News
0
197
May 3, 2021
Intra-Cellular Therapies Applies for FDA Approval of CAPLYTA® (lumateperone) for the Treatment of Bipolar Depression
News
0
239
February 22, 2021
Intra-Cellular Therapies Presents Data Supporting the Potential for Potent and Rapid Antidepressant Activity with Lumateperone
News
2
658
May 8, 2017